Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 225,394,647 papers from all fields of science
Search
Sign In
Create Free Account
S100A2 gene
Known as:
CAN19
, S100 CALCIUM-BINDING PROTEIN A2
, S100 Calcium Binding Protein A2 Gene
Expand
This gene is involved in cell cycle progression and differentiation and may have tumor suppressor activity.
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
17 relations
Breast Carcinoma
CABP1 gene
Calcium Binding
Cell Cycle Control
Expand
Narrower (1)
S100A2 wt Allele
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
The calcium-binding protein S 100 A 2 interacts with p 53 and modulates its transcriptional activity
A. Mueller
,
B. Schäfer
,
+4 authors
C. Heizmann
2017
Corpus ID: 35569837
Head and neck squamous cell carcinoma express high levels of the EF-hand calcium-binding protein S100A2 in contrast to other…
Expand
2012
2012
Predictors of short-term neurocognitive outcome following coronary revascularisation (CABG) depending on the use of cardiopulmonary bypass.
Ines Lazibat
,
Ž. Sutlić
,
K. Brkić
,
B. Nevajda
,
J. Šikić
,
A. Meštrović
Collegium Antropologicum
2012
Corpus ID: 8822313
The purpose of our study was to investigate the association between perioperative cerebral microembolization, expressed as high…
Expand
2011
2011
Loss of Reprimo and S100A2 expression in human gastric adenocarcinoma
Jun Luo
,
Youqing Zhu
,
Guifang Yang
,
L. Gong
,
Bicheng Wang
,
Huan Liu
Diagnostic Cytopathology
2011
Corpus ID: 12258369
Reprimo and S100A2 are two newly identified candidate tumor‐suppressor genes, which play an important role in the regulation of…
Expand
2010
2010
Clinical Omics Analysis of Colorectal Cancer Incorporating Copy Number Aberrations and Gene Expression Data
Tsuyoshi Yoshida
,
Takumi Kobayashi
,
+11 authors
Hiroshi Tanaka
Cancer Informatics
2010
Corpus ID: 8574554
Background Colorectal cancer (CRC) is one of the most frequently occurring cancers in Japan, and thus a wide range of methods…
Expand
2009
2009
Transgenic expression of S100A2 in hairless mouse skin enhances Cxcl13 mRNA in response to solar-simulated radiation
Yong Li
,
J. Gudjonsson
,
+4 authors
James T. Elder
Archives of Dermatological Research
2009
Corpus ID: 22869449
S100A2 is a homodimeric protein that undergoes oxidative cross-linking and translocation from the nucleus to the cytosol in the…
Expand
2005
2005
Establishment of an immortalized cell line from a precancerous lesion of lung adenocarcinoma, and genes highly expressed in the early stages of lung adenocarcinoma development
A. Shimada
,
J. Kano
,
+9 authors
M. Noguchi
Cancer Science
2005
Corpus ID: 39137269
Atypical adenomatous hyperplasia (AAH) is classified as a precancerous lesion of lung adenocarcinoma. We established an…
Expand
1996
1996
Novel specific chemtactic receptor for S100L protein on guinea pig eosinophils.
T. Komada
,
R. Araki
,
K. Nakatani
,
I. Yada
,
M. Naka
,
T. Tanaka
Biochemical and Biophysical Research…
1996
Corpus ID: 24804338
We isolated a new chemotactic protein from bovine lung, and its partial protein sequence analysis indicated that this protein was…
Expand
1996
1996
Novel specific chemotactic receptor for S100L protein on guinea pig eosinophils
駒田 拓也
1996
Corpus ID: 88759242
1996
1996
Interaction of propranolol with S100 proteins of the cardiac muscle.
K. Nakatani
,
Y. Kawanabe
,
A. Kato
,
T. Tanaka
European Journal of Pharmacology
1996
Corpus ID: 43373043
Highly Cited
1989
Highly Cited
1989
Isolation of a new member of the S100 protein family: amino acid sequence, tissue, and subcellular distribution
L. V. Eldik
Journal of Cell Biology
1989
Corpus ID: 17482044
A low molecular mass protein which we term S100L was isolated from bovine lung. S100L possesses many of the properties of brain…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE